Conference Agenda
Day 1, Tuesday, March 29, 2011
7:30 a.m. - 8:30 a.m.
Registration and Continental Breakfast
8:30 a.m. - 8:40 a.m.
Overview Welcome by Co-Chairs
Richard J. Arsenault, Neblett, Beard & Arsenault, Alexandria, LA
Kenneth M. Seeger, Seeger - Salvas LLP, San Francisco
8:40 a.m. - 9:10 a.m.
Overview of the Products: Darvon vs. Darvocet
- Brand Names and Their Differences: Darvon vs. Darvocet
- Popoxyphene, Dextropopoxyphene and Other Preparations
- Number of Prescriptions and Patient Demographics
Gale D. Pearson, Pearson, Randall, Gempeler, Schumacher & LaBore, Minneapolis
Matthew J. McCauley, Parker Waichman Alonso LLP, Port Washington, NY
9:10 a.m. - 9:50 a.m.
The Science of Darvon and Darvocet
- Heart Risks and Cardiotoxicity
- Studies and Evidence of Adverse Effects on the Heart
- Other Available Evidence of Adverse Heart Risks
- Foreign Regulatory Action
- Public Citizen Petitions and Outcomes
- Florida Medical Examiner's Death Data
- Analysis of Adverse Event Reports
- Data Point Surveys from Various State Medicaid Programs
Dawn M. Chmielewski, Climaco, Wilcox, Peca, Tarantino & Garofoli, Co., LPA, Cleveland
Timothy J. Becker, Zimmerman Reed, Minneapolis
10:00 a.m. - 10:45 a.m.
Past Claims and Pending Litigation
- Porter v. Zanodyne Pharmaceuticals Inc. (D.Minn.)
- Differences/Similarities to Other Pharmaceutical Torts
- Rulings on the Liability of Generic Drug Manufacturers: Pliva v. Mensing (U.S.S.C. No. 09-993) and Conte v. Wyeth 85 Cal. Rptr.3d 299 (2008)
Nicholas J. Drakulich, The Drakulich Firm, San Diego
Mark E. Burton Jr., Hersh & Hersh, San Francisco
Mark P. Robinson Jr., Robinson, Calcagnie & Robinson, P.C., Newport Beach
10:45 a.m. - 11:25 a.m.
Civil RICO Implications
John R. Climaco, Climaco, Wilcox, Peca, Tarantino & Garofoli, Cleveland
Mark J. Geragos, Law Offices of Geragos & Geragos, Los Angeles
11:25 a.m. - 12:00 p.m.
Potential Litigation and Defenses
- Where to File: Filings in State and Federal Court
- MDL Considerations
Daniel E. Becnel Jr., Becnel Law Firm, LLC, Reserve, LA
12:45 p.m. - 1:00 p.m.
Registration for Hip Implant-Only Attendees
1:00 p.m. - 1:45 p.m.
Overview of the DePuy Hip and Examination of the Science
- Why the DePuy ASR is Failing
- Anticipated Failure Rates
- Detailed Examination of Physical Injuries
- Problems with Revision Surgeries
John Restaino, DPM, JD, MPH, The Restaino Law Firm, Denver
Eric Kennedy, Weisman Kennedy & Berris Co., L.P.A., Cleveland
Ben W. Gordon Jr., Levin, Papantonio, Thomas, Mitchell, Rafferty & Proctor, P.A., Pensacola, FL
1:45 p.m. - 2:10 p.m.
Damages Analysis: Disability and Impairment Post-Explant
Pete Kaufman, Panish Shea & Boyle, Los Angeles
2:20 p.m. - 2:50 p.m.
Trial Strategies for the DePuy Litigation
- Creative Ways to Explain the Product and Defect to a Jury
- Allowing the Jury to Empathize with a Victim's Pain and Suffering
- DePuy's Punitive Damages Exposure
Michael A. Kelly, Walkup, Melodia, Kelly & Schoenberger, San Francisco
2:50 p.m. - 3:15 p.m.
DePuy MDL Update
Ellen Relkin, Weitz & Luxenberg, New York
Steven J. Skikos, Skikos Crawford Skikos Joseph & Millican, San Francisco
3:15 p.m. - 4:05 p.m.
DePuy California JCCP Update
Matthew Davis, Walkup, Melodia, Kelly & Schoenberger, San Francisco
4:05 p.m. - 4:30 p.m.
Discovery and Case Management Issues
Lawrence J. Gornick, Levin Simes Kaiser & Gornick, San Francisco
Rachel Abrams, Levin Simes Kaiser & Gornick, San Francisco
4:30 p.m. - 4:50 p.m.
Orthopedic Products on the Horizon: DePuy’s Pinnacle Hip
Brian J. Devine, Seeger - Salvas LLP, San Francisco
4:50 p.m. - 5:10 p.m.
Orthopedic Products Update: Zimmer NextGen® Knee
- Zimmer v. Kresch: Advertising Lawyers as Defendants
Hunter J. Shkolnik, Rheingold, Valet, Rheingold, Shkolnik & McCartney, New York
Joseph H. Saunders, Saunders & Walker, Pinellas Park, FL
5:10 p.m. - 5:30 p.m.
Medicare Reimbursement Models for the DePuy Litigation
Elizabeth Vish, Garretson Resolution Group, Inc., Charlotte, NC
Elizabeth Grande, Garretson Resolution Group, Inc., Minneapolis